Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GeoVax Labs, a biopharmaceutical company developing human vaccines for diseases caused by HIV-1 and other infectious agents, has appointed Peter Tsolinas to its board of directors.
Subscribe to our email newsletter
Mr Tsolinas currently serves as chairman and CEO of TMA Group Development, a Chicago-based real estate, architectural and development firm.
Mr Tsolinas has earned a BA degree in architecture with a minor in Byzantine history from the University of Illinois.
Robert McNally, president and CEO of GeoVax, said: “We are very pleased that Mr Peter Tsolinas has agreed to join our board of directors. His substantial business experience will enhance and complement that of our current board members.”